Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Poly(A+) RNAs 3'-seq analysis in the cytoplasmic RNAs of control and U1 AMO treated Hela cells

ABSTRACT: poly(A+) RNAs 3'-seq analysis in the cytoplasmic RNAs of control and U1 AMO treated Hela cells

PROVIDER: PRJNA793684 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17405554_1.fastq.gz	Fastqsanger.gz
	SRR17405554_2.fastq.gz	Fastqsanger.gz
	SRR17405555_1.fastq.gz	Fastqsanger.gz
	SRR17405555_2.fastq.gz	Fastqsanger.gz
	SRR17405556_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

poly(A+) RNAs 3'-seq analysis in the cytoplasmic RNAs of control and U1 AMO treated Hela cells

Project description:To understand if U1-AMO induced truncated forms of mRNAs could be exported into cytoplasm, we performed 3'-seq analysis in the cytoplasmic RNAs of control and U1 AMO treated Hela cells

2023-02-27 | GSE192894 | GEO

ribo-seq in control and U1 AMO treated HeLa cells

Project description:Control and U1 AMO were transfected into Hela cells, Ribosome-associated RNAs were purified and sequenced in Novaseq platform.To compare the translation efficiency, mRNA-seq were performed in parallel.

2023-02-27 | GSE193200 | GEO

wdr33 iCLIP-seq in control and U1 AMO-treated HeLa cells

Project description:To understand the effect of U1 AMO treatment on wdr33 binding profile , we carried out CstF64 iCLIP-seq experiments in HeLa cells treated with either control or U1 AMO.

2023-02-27 | GSE193370 | GEO

CstF64 iCLIP-seq in control and U1 AMO-treated HeLa cells

Project description:To understand the effect of U1 AMO treatment on CstF64 binding profile , we carried out CstF64 iCLIP-seq experiments in HeLa cells treated with either control or U1 AMO.

2023-02-27 | GSE192893 | GEO

ChIP-seq analysis for core 3' processing factors in control and U1 AMO-treated HeLa cells

Project description:To understand the effect of U1 AMO treatment on chromatin binding profiles of core 3' processing factors, we carried out ChIP-seq analysis for several core 3' processing factors after control and U1 AMO treatment

2023-02-27 | GSE193202 | GEO

mRNA polyadenylation profile analysis in control and U1 AMO treated HeLa cells

Project description:To globally assess the effect of polyadenylation site (PAS) usage upon functional knockdown of U1 snRNP, we carried out PAS-seq analysis with control and U1 AMO-treated HeLa cells using the QuantSeq Rev 3' mRNA sequencing library prep kit (Cat. 016-24).

2019-01-22 | GSE125397 | GEO

poly(A+) RNAs 3'-seq analysis in control and U1-specific proteins KD (knock-down) samples

Project description:To understand the effect of U1 snRNP-specific proteins on poly(A+) RNAs profiles, we carried out control and U1A, U1C, U1-70k depletion (using synthetic siRNAs) experiments followed by poly(A+) RNA 3'-seq anlyais using lexogen kit (016.024)in HeLa cells

2023-02-27 | GSE192820 | GEO

Promoter directionality is controlled by U1 snRNP and polyadenylation signals

Project description:Transcription of the mammalian genome is pervasive, but productive transcription outside of protein-coding genes is limited by unknown mechanisms. In particular, although RNA polymerase II (RNAPII) initiates divergently from most active gene promoters, productive elongation occurs primarily in the sense-coding direction. Here we show in mouse embryonic stem cells that asymmetric sequence determinants flanking gene transcription start sites control promoter directionality by regulating promoter-proximal cleavage and polyadenylation. We find that upstream antisense RNAs are cleaved and polyadenylated at poly(A) sites (PASs) shortly after initiation. De novo motif analysis shows PAS signals and U1 small nuclear ribonucleoprotein (snRNP) recognition sites to be the most depleted and enriched sequences, respectively, in the sense direction relative to the upstream antisense direction. These U1 snRNP sites and PAS sites are progressively gained and lost, respectively, at the 5' end of coding genes during vertebrate evolution. Functional disruption of U1 snRNP activity results in a dramatic increase in promoter-proximal cleavage events in the sense direction with slight increases in the antisense direction. These data suggest that a U1-PAS axis characterized by low U1 snRNP recognition and a high density of PASs in the upstream antisense region reinforces promoter directionality by promoting early termination in upstream antisense regions, whereas proximal sense PAS signals are suppressed by U1 snRNP. We propose that the U1-PAS axis limits pervasive transcription throughout the genome. 3' end sequencing of poly (A) + RNAs in mouse ES cells with and without U1 snRNP inhibition using antisense morpholino oligonucleotides (AMO). Each with two biological replicates.

2013-06-28 | E-GEOD-46433 | biostudies-arrayexpress

Gene expression profiling reveals cytoplasmic U1 snRNA accumulation may cause cancers

Project description:In this study, we built a model of cytoplasmic aggregation of U1 snRNA in a rat cell line. By comparing the gene expression profiling of U1 snRNA accumulated cells with their controls, 916 (about 4% of 20,000) genes were identified significantly differentially expressed. These 595 over-expressed genes and 321 repressed genes were further analyzed by GO and KEGG pathway enrichment. As a result, three of 12 enriched pathways are well-known cancer pathways, while nine of them were associated to cancers in previous studies. These findings suggest that cytoplasmic U1 snRNA accumulation may cause cancers.

2016-07-13 | GSE84304 | GEO

ribo-seq in control and U1 AMO treated HeLa cells

Project description:ribo-seq in control and U1 AMO treated HeLa cells

| PRJNA795419 | ENA